- Home
- MNMD vs IIIN Comparison
MNMD vs IIIN Comparison
Compare MNMD & IIIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNMD
- IIIN
- Stock Information
- Founded
- MNMD 2019
- IIIN 1953
- Country
- MNMD United States
- IIIN United States
- Employees
- MNMD N/A
- IIIN N/A
- Industry
- MNMD Pharmaceuticals and Biotechnology
- IIIN Steel/Iron Ore
- Sector
- MNMD Health Care
- IIIN Industrials
- Exchange
- MNMD Nasdaq
- IIIN Nasdaq
- Market Cap
- MNMD 509.2M
- IIIN 704.8M
- IPO Year
- MNMD N/A
- IIIN N/A
- Fundamental
- Price
- MNMD $7.85
- IIIN $39.65
- Analyst Decision
- MNMD Strong Buy
- IIIN
- Analyst Count
- MNMD 7
- IIIN 0
- Target Price
- MNMD $26.29
- IIIN N/A
- AVG Volume (30 Days)
- MNMD 1.2M
- IIIN 130.6K
- Earning Date
- MNMD 08-12-2025
- IIIN 07-17-2025
- Dividend Yield
- MNMD N/A
- IIIN 2.82%
- EPS Growth
- MNMD N/A
- IIIN N/A
- EPS
- MNMD N/A
- IIIN 1.16
- Revenue
- MNMD N/A
- IIIN $570,455,000.00
- Revenue This Year
- MNMD N/A
- IIIN $22.06
- Revenue Next Year
- MNMD N/A
- IIIN $6.70
- P/E Ratio
- MNMD N/A
- IIIN $34.30
- Revenue Growth
- MNMD N/A
- IIIN N/A
- 52 Week Low
- MNMD $4.70
- IIIN $22.49
- 52 Week High
- MNMD $10.44
- IIIN $40.03
- Technical
- Relative Strength Index (RSI)
- MNMD 61.23
- IIIN 68.27
- Support Level
- MNMD $6.95
- IIIN $38.24
- Resistance Level
- MNMD $8.11
- IIIN $40.03
- Average True Range (ATR)
- MNMD 0.41
- IIIN 0.94
- MACD
- MNMD 0.12
- IIIN 0.20
- Stochastic Oscillator
- MNMD 85.27
- IIIN 88.72
About MNMD Mind Medicine (MindMed) Inc.
Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).
About IIIN Insteel Industries Inc.
Insteel Industries Inc manufactures steel wire reinforcing products for concrete construction applications. It manufactures and markets PC strand and welded wire reinforcement, including ESM, concrete pipe reinforcement, and standard welded wire reinforcement. The company's products are sold to manufacturers of concrete products that are used in nonresidential construction. Its concrete reinforcing products consist of two product lines: PC strand and WWR. Insteel generates its geographical revenue from the United States.